Characterization of the T-cell epitopes of a major peanut allergen, Ara h 2

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 60, Issue 1, 2005, Pages 35-40

  Glaspole, I M ^a,b   De Leon, M P ^b   Rolland, J M ^b   O'Hehir, R E ^a,b  

^a ALFRED HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Allergens; Ara h 2; Peanut; T cell epitopes

Indexed keywords

ALLERGEN; CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 5; PEANUT ALLERGEN ARA H 2; UNCLASSIFIED DRUG;

ADULT; ALLERGENICITY; ANAPHYLAXIS; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CYTOKINE PRODUCTION; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; FEMALE; HUMAN; IMMUNOGENICITY; IMMUNOTHERAPY; MALE; NUCLEOTIDE SEQUENCE; PEANUT ALLERGY; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; T LYMPHOCYTE ACTIVATION; TH2 CELL; VACCINATION;

ADULT; BLOTTING, WESTERN; CELL LINE; CELL PROLIFERATION; CYTOKINES; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; PEANUT HYPERSENSITIVITY; PEPTIDE FRAGMENTS; PLANT PROTEINS; T-LYMPHOCYTES; TH2 CELLS;

EID: 12444292119     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2004.00608.x     Document Type: Article

References (23)

1. Sampson HA, Mendelson L, Rosen JP. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med 1992;327:380-384.
2. Primeau MN, Kagan R, Joseph L, Lim H, Dufresne C, Duffy C et al. The psychological burden of peanut allergy as perceived by adults with peanut allergy and the parents of peanut-allergic children. Clin Exp Allergy 2000;30: 1135-1143.
3. Noon L. Prophylactic inoculation against hay fever. Lancet 1911;1: 1572-1573.
4. Oppenheimer JJ, Nelson HS, Bock SA, Christensen F, Leung DY. Treatment of peanut allergy with rush immunotherapy [see comments]. J Allergy Clin Immunol 1992;90:256-262.
5. Nelson HS, Lahr J, Rule R, Bock A, Leung D. Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J Allergy Clin Immunol 1997;99:744-751.
6. Litwin A, Pesce AJ, Michael JG. Regulation of the immune response to allergens by immunosuppressive allergenic fragments: 1. Peptic fragments of honeybee venom phospholipase A2. Int Arch Allergy Appl Immunol 1988;87:361-366.
7. Larche M. Anti-T-cell strategies in the treatment of allergic disease. Allergy 2002;57(Suppl. 72):20-23.
8. Muller U, Akdis CA, Fricker M, Akdis M, Blesken T, Bettens F et al. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom. J Allergy Clin Immunol 1998;101:747-754.
9. Oldfleld WL, Larche M, Kay AB. Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial. Lancet 2002;360:47-53.
10. Rolland JM, Douglass J, O'Hehir RE. Allergen immunotherapy: current and new therapeutic strategies. Expert Opin Investig Drugs 2000;9:515-527.
11. de Leon MP, Glaspole IN, Drew AC, Rolland JM, O'Hehir RE, Suphioglu C. Immunological analysis of allergenic cross-reactivity between peanut and tree nuts. Clin Exp Allergy 2003;33: 1273-1280.
12. Sutherland MF, Drew AC, Rolland JM, Slater JE, Suphioglu C, O'Hehir RE. Specific monoclonal antibodies and human immunoglobulin E show that Hev b 5 is an abundant allergen in high protein powdered latex gloves. Clin Exp Allergy 2002;32:583-589.
13. Stanley JS, King N, Burks AW, Huang SK, Sampson H, Cockrell G et al. Identification and mutational analysis of the immunodominant IgE binding epitopes of the major peanut allergen Ara h 2. Arch Biochem Biophys 1997;342:244-253.
14. de Silva HD, Sutherland MF, Suphioglu C, McLellan SC, Slater JE, Rolland JM et al. Human T-cell epitopes of the latex allergen Hev b 5 in health care workers. J Allergy Clin Immunol 2000;105:1017-1024.
15. Burks AW, Williams LW, Connaughton C, Cockrell G, O'Brien TJ, Helm RM. Identification and characterization of a second major peanut allergen, Ara h II, with use of the sera of patients with atopic dermatitis and positive peanut challenge. J Allergy Clin Immunol 1992;90:962-969.
16. Kleber-Janke T, Crameri R, Appenzeller U, Schlaak M, Becker WM. Selective cloning of peanut allergens, including profllin and 2S albumins, by phage display technology. Int Arch Allergy Immunol 1999;119:265-274.
17. Rabjohn P, Helm EM, Stanley JS, West CM, Sampson HA, Burks AW et al. Molecular cloning and epitope analysis of the peanut allergen Ara h 3. J Clin Invest 1999;103:535-542.
18. Burks W, Sampson HA, Bannon GA. Peanut allergens. Allergy 1998;53: 725-730.
19. Bernard H, Paty E, Mondoulet L, Burks AW, Bannon GA, Wal JM et al. Serological characteristics of peanut allergy in children. Allergy 2003;58:1285-1292.
20. Gardner LM, O'Hehir RE, Rolland JM. High dose allergen stimulation of T cells from house dust mite-allergic subjects induces expansion of IFN-gamma + T cells, apoptosis of CD4 + IL-4+ T cells and T cell anergy. Int Arch Allergy Immunol 2004;133:1-13.
21. Rabjohn P, West CM, Connaughton C, Sampson HA, Helm RM, Burks AW et al. Modification of peanut allergen Ara h 3: effects on IgE binding and T cell stimulation. Int Arch Allergy Immunol 2002;128:15-23.
22. Sen M, Kopper R, Pons L, Abraham EC, Burks AW, Bannon GA. Protein structure plays a critical role in peanut allergen stability and may determine immunodominant IgE-binding epitopes. J Immunol 2002;169:882-887.
23. Haselden BM, Kay AB, Larche M. Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions. J Exp Med 1999;189:1885-1894.